Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma

NCT03630913 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.

NCT NCT03630913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03630913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma
Lead sponsor
Institut Cancerologie de l'Ouest
Phase
Not applicable
Overall status
Unknown status
Start date
January 8, 2019
Completion date
October 31, 2023
Enrollment
385 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

axillary metastases, invasive breast cancer